See every side of every news story
Published loading...Updated

Scientists say 40p worth of superfood every week can almost halve Alzheimer's risk

  • Two studies published in JAMA Neurology found links between certain diabetes drugs and lower dementia risk.
  • Rising rates of Alzheimer's and dementia globally prompted research into preventative measures for at-risk individuals.
  • Researchers analyzed data from over 90,000 individuals, comparing GLP-1RAs and SGLT2is to other glucose-lowering treatments.
  • One study showed GLP-1RAs reduced dementia risk by 33%, while SGLT2is showed a 43% reduction; Guo stated results are "very promising."
  • These findings suggest GLP-1RAs and SGLT2is may offer neuroprotective benefits, but researchers call for further investigation.
Insights by Ground AI
Does this summary seem wrong?

23 Articles

All
Left
2
Center
8
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 73% of the sources are Center
73% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Tuesday, April 8, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.